<html>
<head>PUBMED IDs for CTNNAP1</head>
<body bgcolor='#C5F0F2'><h1>CTNNAP1</h1><a href='https://pubmed.ncbi.nlm.nih.gov/7601473/'>Isolation and characterization of a human pseudogene (CTNNAP1) for alpha E-catenin (CTNNA1): assignment of the pseudogene to 5q22 and the alpha E-catenin gene to 5q31.</a> March 20  1995<br><a href='https://pubmed.ncbi.nlm.nih.gov/27487124/'>Downregulated pseudogene CTNNAP1 promote tumor growth in human cancer by downregulating its cognate gene CTNNA1 expression.</a> August 4  2016<br><a href='https://pubmed.ncbi.nlm.nih.gov/27487108/'>Impact of XRCC1, GSTP1, and GSTM1 Polymorphisms on the Survival of Ovarian Carcinoma Patients Treated with Chemotherapy.</a> April 4  2016<br><a href='https://pubmed.ncbi.nlm.nih.gov/27487099/'>The role of talimogene laherparepvec (T-VEC) in the age of checkpoint inhibitors.</a> February 7  2016<br><a href='https://pubmed.ncbi.nlm.nih.gov/27487097/'>Long-Term Outcomes, Genetics, and Pituitary Morphology in Patients with Isolated Growth Hormone Deficiency and Multiple Pituitary Hormone Deficiencies: A Single-Centre Experience of Four Decades of Growth Hormone Replacement.</a> August 4  2016<br></body></html>
